Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
L
|
Lucara Diamond Corp
OTC:LUCRF
|
CA |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XMUN:SLL
|
AT |
|
A
|
Amdocs Ltd
XMUN:AOS
|
US |
Shareholder Yield
Current shareholder yield for 
20D0 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
20D0 Price
Cidara Therapeutics Inc
| Average Annual Return | 4.29% |
| Standard Deviation of Annual Returns | 58.03% |
| Max Drawdown | -80% |
| Market Capitalization | 6.5B EUR |
| Shares Outstanding | 31 450 000 |
| Percentage of Shares Shorted |
N/A
|
20D0 Return Decomposition
Main factors of price return
Stock Splits
20D0's latest stock split occurred on Apr 24, 2024
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, 20D0 traded at 0.478 per share. Afterward, the share price was about 9.56.
The adjusted shares began trading on Apr 24, 2024. This was the only stock split in 20D0's history.
